Thus suppression of FABP5 expression in a highly malignant prostate cancer cell line PC3-M significantly reduced their invasiveness in vitro [13] and inhibited their tumorigenicity in vivo by reducing the level of VEGF and microvessel densities. The gene discussed is FABP5; the disease is prostate carcinoma.